"Tandem Clinical Research is a dedicated, phase I-IV, clinical trials center. We specialize in the performance of clinical trials for pharmaceutical, biotech and medical device companies. All medical service is provided free of charge by board-certified physicians. The mission of Tandem Clinical Research is to advance the science of medicine while improving the quality of life of our patients. Our medical team believes in providing exemplary care to our patients while conducting research with compassion and respect to our study participants. We offer medical research opportunities to men and women in New Orleans."

During the past decade, Tandem Clinical Research conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 21 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 21 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tandem Clinical Research" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tandem Clinical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Beaufort" with 1 trials as a collaborator, "Chemo Research" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Tandem Clinical Research" are "Nonalcoholic Steatohepatitis" (7 trials), "Crohn Disease" (4 trials), "Gastroparesis" (4 trials), "NASH - Nonalcoholic Steatohepatitis" (4 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "Tandem Clinical Research" in a lesser frequency.

Most popular intervention types in "Tandem Clinical Research" are "Drug" (62 trials), "Other" (10 trials), "Device" (4 trials), "Biological" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Ozanimod" (3 trials), "Relamorelin" (3 trials), "Vonoprazan" (3 trials) and "BMS-986036" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tandem Clinical Research" are 66 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Tandem Clinical Research". undefined are not yet recruiting, 22 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Tandem Clinical Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Tandem Clinical Research, 4 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".